Welcome to the Ulipristal Pregnancy Registry

This pregnancy registry is a joint initiative and is developed by the following pharmaceutical companies:
  • Aristo Pharma GmbH
  • Aspen Healthcare Malta Limited
  • ELPEN Pharmaceutical Co. Inc
  • Eugia Pharma (Malta) Ltd.
  • Exeltis Pharmaceuticals Holding, S.L.
  • Farmitalia s.r.l
  • Mylan
  • Hexal AG
  • STADA Arzneimittel AG
  • Zentiva Group, a.s.
A complete list of companies affiliated with this registry can be found via the following link:  Affiliates
This pregnancy registry is aimed at collecting medical data about pregnancy outcomes in women exposed to Ulipristal 30 mg.
If you are a woman who used ulipristal 30 mg at any time during pregnancy or used ulipristal 30 mg during the menstrual cycle in which a pregnancy started and want to obtain general information on the pregnancy registry and access the on-line questionnaire, please click on ‘Woman’ below. Woman
If you are a health care provider, please click on 'Health Care Provider' below to read information on this registry and access the on-line questionnaire. Health Care Provider